This meeting presented opportunities for discussion on which factors make Canada an attractive place to undertake vaccine research, and what are the barriers that make Canada less competitive. Through having perspectives from different stakeholders, this meeting was able to explore how the Canadian landscape fares with other key countries/regions as well as to strategize potential solutions to minimize barriers.
Summary of Discussion: The Canadian vaccinology landscape in a global context
Previous
Previous
Summary of Discussion: Respiratory Syncytial Virus (RSV) Vaccine Safety and Pharmacovigilance
Next
Next